IFNG and breast carcinoma: The few studies we identified exploring the association between IFN-γ and breast cancer risk in breast cancer patients versus controls (unspecified menopausal status) suggested either no difference [42] (250 aged-matched case–control pairs) or lower concentrations in cases [43] (29 controls, 55 patients not receiving chemotherapy, 32 receiving chemotherapy).